Evonik completes its system solutions portfolio with acquisition of Infinitec Activos, a cosmetic active delivery technology company

• Strong technical and strategic alignment facilitates the transformation of Evonik's Nutrition and Consumer Chemicals business unit into a system solutions provider

• Enhancing Evonik's ability to provide scientifically proven innovative efficacy claims

• Seven patented delivery technologies included in the acquisition will enhance existing active delivery systems, several

Novel natural active ingredients to expand portfolio of bio-based actives Evonik has signed an agreement to acquire InfinitecActivos , a Spanish private technology company, which is expected to close in July
.
Infinitec Activos focuses on the development and production of novel active delivery systems for cosmetic active ingredients
.
Following the acquisition, the InfinitecActivos business will be integrated into the Evonik Care Chemicals business line, thereby further complementing the Actives Delivery Systems business acquired in 2017
.

The acquisition will facilitate the transformation of Evonik's Nutrition and Consumer Chemicals business unit into a system solutions provider
.
The goal is to increase the market share of system solutions from the current 20% to more than 50% by 2030 .
This business unit has high growth prospects and above-average earnings potential .
 

Yann d'Hervé  , head of the Care Chemicals business line at Evonik, said: "Proven effective active delivery systems can provide scientific efficacy claims for the development of new cosmetic ingredients, creating opportunities for personal care brands to differentiate themselves
.
"

Infinitec Activos  has a variety of natural active ingredient products and seven conduction technologies
.
The integration of these businesses into the Care Chemicals business line will strengthen Evonik's position as a partner for sustainable raw materials and further diversify the division's technology platform
.
By integrating its existing actives portfolio with the newly acquired delivery technology, Evonik will significantly enhance its ability to deliver innovative scientific efficacy claims and further unlock the potential for synergies across platforms
.

Alfonso Hidalgo , Partner,  Infinitec Activos SL ,  said: "We believe that the synergies created by this acquisition will not only benefit our customers and acquirers, but will also create new opportunities for the entire personal care and beauty product value chain
.
"

This acquisition once again demonstrates the strong acquisition capability of Evonik's Nutrition and Consumer Chemicals business unit
.
Since 2016 , the business unit has acquired 10 strong companies with complementary technologies to continuously enhance the overall competitiveness of its product portfolio
.
These successful business integrations have opened up new markets for Evonik, accelerated business growth and created considerable value
.

The acquisition involves 47 employees of Infinitec Activos , who work at the company's headquarters in Barcelona's Science Park, at its production site in Montornés del Vallès , Spain, and at its natural raw material production company, Naturethic .
Founded in 2004, Infinitec Activos focuses on research and innovation to establish a new generation of active ingredient delivery systems, and has a high-quality scientific research and marketing team .
Infinitec Activos serves clients ranging from small independent brands to globally recognized brands .

Infinitec Activos is focused on providing customers with personalized products such as its well-known patented technology for auto-targeting of active ingredients, as well as its new generation of delivery systems based on poly(lactic-co-glycolic acid) ( PLGA )
.
The company's next-generation active targeting delivery system contains active ingredients at the core and modifies surface particles with two peptides for dual-modal cell targeting
.
Evonik plans to apply this patented technology to adjacent markets such as medicine in the future, where Evonik has already promoted liposome delivery technology
.